Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Jul 7, 2009; 15(25): 3073-3085
Published online Jul 7, 2009. doi: 10.3748/wjg.15.3073
Published online Jul 7, 2009. doi: 10.3748/wjg.15.3073
Authors | Target | Herbs (scientific name) | Dose/duration | Groups | Main outcome | Other relevant effects & complications |
Wang et al[27] 2000 | Rat (obese) | Haidonghua powder: Laminaria japonica Aresch & Benincasa hispida (Thunb.) Cogn. etc | (2.5 g/kg) | - | Sig. decrease in Lee’s index & size of fat cells | Did not influence the function of thyroid gland & metabolism of water & salt |
Jeon et al[28] 2003 | Mouse | Rhus vemiciflua Stokes | 8 wk | C: HFD I: HFD + extract | Sig. suppression of body wt. gain and lower wt. of subcutaneous adipose tissue | Lowered plasma TG |
Alarcon-Aguilar et al[29] 2007 | Mouse | Hibiscus sabdariffa | 120 mg/kg 60 d | C: Healthy & obese (by MSG) + placebo I: Same groups + extract | Sig. decrease in body wt. gain in obese mice & increased liquid intake in both groups | No sig. change in TG & Chol levels. Increase in ALT levels was shown but was not sig. |
Urías-Silvas et al[30] 2008 | Mouse | Fructans extracted from Agave tequilana (TEQ) and Dasylirion spp (DAS) | 10% supplement | C: STD I: STD + Raftilose/DAS/TEQ | Sig. decrease in body wt. gain & food intake. The (TEQ) group had the lowest value | Lower serum glucose & Chol level but Sig. decrease in TG levels was shown in Raftilose group. Higher concentration of GLP-1 & it's precursor & proglucagon mRNA in I groups |
Park et al[31] 2007 | Rat | Platycodon grandiflorum | 150 mg/kg 7 wk | C: NLD/HFD I: Same groups + extract | Sig. decrease in body wt & subcutaneous adipose tissue wt. & adipocytes size in I group | Sig. decrease in plasma TG & Chol concentrations, up-regulation of FABP mRNA expression induced by HFD |
Jongwon et al[32] 2005 | Rat (obese by HFD) | Allium victorialis var. platyphyllum leaves | 100 mg/kg 2 wk | - | Considerable reduction of retroperitoneal, epididymal and total abdominal fat pad wt. | Sig. decrease in hyperlipidemia and increased lipid content in feces |
Kobayashi et al[33] 2001 | Rat | Evodiamine an alkaloid of a fruit: Evodia rutaecarpa | 0/02%, 0/03% of the diet 12 wk | C: Control I: Extract | Sig. decrease in perirenal fat wt. & decrease of epididymal fat mass | Sig. decrease of lipid in liver & serum FFAs. Sig. increase of lipolytic activity in perirenal fat tissue & specific GDP binding in brown adipose tissue mitochondria as the biological index of heat production |
Jin et al[34] 1994 | Rat | Jiang-zhi jian-fei yao: the refined Rhubarb | Injected intragastrically | No sig. increase in body wt. but reduction of food intake. Decreased size of abdominal adipose cells | Prolongation of stomach evacuation time and acceleration of intestinal movements | |
Kim et al[35] 2008 | Rat | Juniperus chinensis | 1% supplement/79 d | C: NLD/HFD I: HFD + extract | Sig. decrease in body wt gain & visceral fat pad wt. | Sig. decrease in blood lipid, leptin & insulin levels. Sig. reversal of the down-regulation of genes implicated in adipogenesis & increased gene expressions & phosphorylations related to FABO |
Shih et al[36] 2008 | Mouse (obese by HFD) | Momordica charantia (bitter melon) | 4 wk | C: Control I: Rosiglitazone/extract | Sig. decrease in epididymal white adipose tissue wt. & visceral fat wt. | Sig. improvement in blood glucose, leptin, and FFA. Influenced PPARα/PPARγ expression |
Pang et al[37] 2008 | Rat (obese by HFD) | Ilex paraguariensis | Sig. decrease in body wt. of visceral fat-pad wt. | Sig. decrease in blood and hepatic lipid, glucose, insulin and leptin levels. Reversed the down-regulation of genes implicated adipogenesis, thermogenesis & enhanced expression of uncoupling proteins in adipose tissue | ||
Bruno et al[38] 2008 | Mouse | Green tea | 0%, 1%, 2% (wt.:wt.)/6 wk | C: Obese/lean I: Same groups + extract | Sig. decrease in body wt. of both I groups | In obese I group, sig. decrease in hepatic steatosis was observed dose dependently. Liver enzymes decreased. 30%-41% and 22%-33% lower serum ALT and AST activities were shown, respectively |
Lee et al[39] 2008 | Mouse | A combination of Morus alba, Melissa officinalis and Artemisia capillaries | 12 wk | - | Sig. decrease in body wt. gain & adipose mass | Decreased serum levels of TG, Chol & inhibited hepatic lipid accumulation, and increased hepatic mRNA levels of enzymes responsible for FABO |
Choi et al[40] 2008 | Mouse (obese by HFD) | Cucurbita moschata | 500 mg/kg 8 wk | _ | Sig. suppression of body wt. & fat storage increase but amount of food intake was not affected | |
Huang et al 2008[41] | Rat | Momordira charantia L. (Bitter melon) | 5% | C: HFD I1: HFD + plant I2: HFD + thiazolidinedione | Sig. decrease in the number of large adipocytes in both I groups. Sig. decrease in adipose tissue mass in I1 group compared to I2 group | Sig. decrease in enzymes of adipose tissue implicating reduction of insulin resistance in I group as compared to C group |
Lemaure et al[42] 2007 | Rat (obese) | Cyperus rotundus L. tubers | 45, 220 mg/kg 60 d | _ | Sig. decrease in wt. gain without affecting food consumption | |
Lei et al[43] 2007 | Mouse | Pomegranate leaf | 400/800 mg per kilogram 5 wk | C: HFD/NLD I: Same groups + extract | Sig. decrease in body wt. & energy intake and adipose pad wt. percents in I. group. Sig. decrease in appetite of obese mice on NLD was shown | Sig. decrease in serum TG, Chol, glucose levels & Chol/HDL ratio, inhibition of intestinal fat absorption |
Aoki et al[44] 2007 | Mouse (obese by HFD) | Licorice flavonoids oil (LFO) | 0/5%, 1%, 2% 8 wk | C: Placebo I: Extract | Sig. decrease of abdominal white adipose tissue & body wt. gain with 1% & 2% LFO groups, decrease of adipocyte size | Improvement of fatty degeneration of hepatocytes and changes in genes implicating regulation of lipid metabolism with 2% concentration |
Oluyemi et al[45] 2007 | Rat | Garcinia cambogia seed (bitter cola) | 200, 400 mg/kg 5 wk | C: Placebo I: Extract | Sig. decrease in body wt. | Sig. decrease in TG pool of adipose tissue & liver but sig. increase of HDL & decreased LDL |
Han et al[46] 2006 | Mouse (obese by HFD) | Kochia scoparia | 1%, 3%/3 d | - | Prevented the increases in body & parametrial adipose tissue wt. | Sig. increase the fecal content & fecal TG levels in day 3 |
Goyal et al[47] 2006 | Mouse (obese gold thioglucose) | Zingiber officinale | 250 mg/kg 8 wk | C: Placebo I: Extract | Sig. decrease in body wt. | Sig. decrease in serum Chol, TG, glucose, and insulin |
Kishino et al[48] 2006 | Rat and mouse | Salacia reticulata | 0/5% 8 wk in mice 0/2% 35 d in rats | C: HFD I: HFD + plant | Sig. decrease in the body wt. and visceral fat mass increase | Sig. decrease in plasma TG, 4 h after ingestion; Sig. decrease in energy efficiency, plasma leptin and adiponectine levels |
Jayaprakasam et al[49] 2006 | Mouse | Cornelian cherry (cornus mas) (Purified anthocyanins (A) & ursolic acid (u) | 1 g/kg (A), 500 mg/kg (u) 8 wk | C: HFD I: HFD + A/A + u | 24% decrease in wt. gain in (A) group | Elevated insulin levels; Sig. decrease of liver TG in A + u group |
Moreno et al[50] 2006 | Rat | Arachis hypogaea nutshell | 1% (wt:wt)/12 wk | C: HFD I: HFD + extract | Sig. decrease in body wt. gain and liver size | Increased fecal lipid excretion. Reduced TG content of liver and serum glucose and insulin |
Galisteo et al[51] 2005 | Rat (obese) | Plantago Ovata | 3/5% 25 wk | C: STD I: STD + extract | Sig. decrease in body wt. gain | Sig. improvement of lipid profile, FFA & insulin & TNF-α & hypoadinectinemia |
Zhao et al[52] 2005 | Mouse (obese by hyperalimentation) | Phillyrin (Fructose forsythia) | Sig. decrease in wet wt. of fat & fat index & diameter of fat cells & lee index | Decrease in jejunum microvillus area, and serum levels of TG & Chol | ||
Chen et al[53] 2005 | Rat | Bitter melon (Momordica charantia) | 0/75% or 7/5 g per kilogram 7 wk | C: LFD/HFD I: LFD/HFD + extract | Lower energy efficiency and visceral fat mass after 4 wk in I group | Reduced plasma glucose and hepatic TG but higher serum FFA after 4 wk; Higher plasma catecholamine after 7 wk in I group; Sig. decrease in hepatic TG & steatosis and sig. increase of serum epinephrine & FFA in HFD group of I |
Han et al[54] 2005 | Rat | Coleus forskohlii | 50 g/kg | C: Sham operated/ovariectomized + control diet I: Same groups + extract | Reduced body wt.& food intake & fat accumulation | |
Han et al[55] 2005 | Mouse | Chikusetsu saponins isolated from Panax japonicus rhizomes | 1%, 3%/9 wk | C: HFD I: HFD + extract | Prevented body wt. gain & increase of parametrial adipose tissue wt. | Sig. increase of the fecal content & TG level in day 3; reduction of plasma TG 2 h after oral lipid intake & inhibition of pancreatic lipase activity |
Han et al[56] 2005 | Mouse | Zingiber officinale Roscoe | 1%, 3%/8 wk | C: HFD I: HFD + plant | Sig. decrease in body wt. gain at 2-8 wk with 3% & in final parametrial adipose tissue wt. with 1% concentration | |
Cha et al[57] 2004 | Mouse | Acanthopanax senticosus | 0/5 g per kilogram 12 wk | C: NLD/HFD I: NLD/HFD + extract | HFD group of I had lower wt. gain but no difference in food consumption was shown | In HFD group of I, lower serum LDL and restoration of liver TG at the same level as fed by LFD was shown; No alteration in carnitine status |
Kim et al[58] 2005 | Rat | Crude saponin of Korean red ginseng | 200 mg/kg 3 wk, ip | C: NLD/HFD I: NLD/HFD + extract | Reduced body wt., food intake & fat content in HFD group of I similar to those fed with NLD | Reduction of hypothalamic NPY expression and serum leptin level in HFD group of I |
Yun et al[59] 2004 | Mouse | Wild Ginseng | 250, 500 mg/kg | C: HFD I: HFD + extract | Sig. inhibition of body wt. gain dose dependently. Decrease of white & brown adipocytes diameters | Sig. inhibition of FBG, TG, and FFAs dose-dependently; insulin resistance improved |
Junbao et al[60] 2004 | Rat (obese) | Semen cassiae | 6% | - | Sig. decrease in body wt. & lee index | Reduction of fasting serum TG, insulin & malondialdehyde |
Kim et al[61] 2004 | Rat | Adlay seed (CoixLachrymajobi var. mayuen) | 50 mg/100 g of body wt. | C1: NLD C2: HFD + saline (sham group) I: HFD + plant | Sig. decrease in body wt. & food intake & epididymal and peritoneal fat & white adipose tissue size as compared to sham group | Increase of brown adipocytes as compared to NLD group but not significant |
Kwon et al[62] 2003 | Rodent | Dioscorea nipponica Makino | 5%/8 wk | C: HFD I: HFD + plant | Sig. decrease in body wt. & adipose gain | Suppression of time dependent increase of serum TG level after lipid intake |
Lu et al[63] 1999 | Rat (obese by hyperalimentation) | Inspissation tea (Guangdong kudingcha) | C: Control I1: Extract I2: Fenfluramine | Stronger modulation on lymphocytes hypertrophy and quantity was shown in I1 group | Only fenfluramine showed sig. difference in small intestine villus model | |
Yoshikawa et al[64] 2002 | Rat (obese) | Salacia reticulata | 125 mg/kg 27 d | Suppression of body wt. and periuterine fat storage increase in female rats but no effect on male rats | ||
Xie et al[65] 2002 | Mouse | Ginseng berry | 150 mg/kg 12 d, ip | C: Diabetic/lean diabetic + placebo I: Same groups + extract | Sig. decrease in body wt. as compared to day 0 in diabetic group of I. wt. loss in lean mice was shown | Sig. increase in glucose tolerance in diabetic mice but no sig. decrease of FBG in lean mice. |
Yamamoto et al[66] 2000 | Rat | CT-II, an extract from Nomame Herba | 8 wk, 12 wk, 6 mo | C: Lean/obese + HFD I: Same groups + HFD + plant | Sig. inhibition of body wt. gain dose dependently without affecting food intake in lean rats after 12 wk. Sig. decrease in body wt. gain in obese mice after 24 wk | Sig. inhibition of TG elevation |
Han et al[67] 1999 | Mouse | Oolong tea | 10 wk | C: HFD I: HFD + extract | No sig. difference in food intake but prevented obesity & liver induced by a HFD | Enhancement of noradrenalin induced lipolysis & inhibition of pancreatic lipase activity |
Pusztai et al[68] 1998 | Rat | Kidney bean (Phaseolus vulgaris) | 130, 150, 280 g/kg 10-70 d | C: Lean/obese + LFD/HFD I: Same groups + extract | The growth was retarded dose-dependently lower body fat | Sig. decrease of body protein in lean I group. Sig. decrease in plasma insulin levels in obese I group. Sig. pancreatic growth after long term feeding in all I groups |
Nagasawa et al[69] 1991 | Mouse (obese) | Tree peony root (Paenia suffruticosa) | 0/5% 30 wk | C: Control I: Extract | Sig. decrease in food intake and Lee index | Improvement in glucose tolerance. No sig. difference in serum FFA levels |
Wang et al[70] 2008 | Mouse | Parasitic loranthus from Loranthacea or Viscaceae | 20 d | - | Sig. decrease in body wt. & food intake | High inhibitory ability on FAS-Loran thacea was nearly 400 fold stronger than that from the viscaceae |
Hu et al[71] 2008 | Mouse (female) | Escins extracted from Aesculus turbinata Blume (Hippocastanaceae) | 2%/11 wk | I: HFD C: HFD + extract | Suppressed the increase in body & parametrial adipose tissue wt. | Suppressed the increase of liver TG content; increased TG in feces after fat ingestion |
Ohkoshi et al[72] 2007 | Mouse | Nelumbo nucifera Gaertn leaves (Nymphaceae) | 50% | C: STD/HFD I: Same groups + extract | Sig. suppression of body wt. gain | Exhibition of lipolytic activity especially in visceral adipose tissue; β adrenergic receptor pathway was partly involved |
Kang et al[73] 2004 | Rat | PM-F2-OB composed of Lycii Fructus, Rehmanniae Radix, Coicis Semen, Carthami Flos, Hoelen, Angelicae Radix, Nelumbinis Semen, Radix Dioscorea and Aurantii Fructus | 6 wk | C: STD/HFD I: Same groups + plant | No sig. difference in wt. change if STD was used but in HFD group of I resulted in sig. decrease in body wt. gain but showed no sig. difference in amount of food intake | Sig. decrease in serum Chol/LDL and total lipids; reduction of kidney fat wt./FFA/PL & TG to levels equal or below the normal diet |
Mary et al[74] 2003 | Rabbit | Caps HT2 A herbal formulation | 5 mg/kg (iv) 30 d 100/200/300/400/mg per kilogram orally | - | Sig. decrease in body wt. | Sig. increase in HDL after oral administration and decrease in atherogenic index in oral administration; Sig. increase of the release of LPL enzyme and sig. hypolipidemic effect in IV groups |
Wu et al[75] 2005 | Rat (diabetic by STZ ) | Astragalus polysaccharide (APS) a component of Astragalus membranaceus roots | 400 mg/kg (APS) 5 wk | - | Sig. decrease in body wt. | Sig. decrease in plasma glucose; improved insulin sensitivity |
Xie et al[76] 2005 | Mouse (Genetically obese) | Total, Ginsenosides in Chinese ginseng (TG CG), from leaves and the stem of Panax ginseng | 100, 200 mg/kg (ip) 12 wk & 150, 300 mg/kg (oral)/12 wk | C: Placebo I: Extract | Sig. decrease in body wt. | Sig. decrease in FBG in 200 mg/kg dose after injection Sig. decrease in FBG in 300 mg/kg dose |
Palit et al[77] 1999 | Mouse | Galega officinalis | 10% (w/w) of the diet 28 d | C: Diabetic/NL I: Same groups + plant | Sig. decrease in body wt. in both I groups, sig. wt. loss in normal mice independent of a reduction in food intake but in diabetic mice wt. loss was with reduced food intake | Striking loss of body fat in both groups; Sig. decrease in serum glucose in both groups but Sig. decrease in serum insulin in diabetic mice |
Oi et al[78] 1999 | Rat | Garlic | 8 g/kg of diet 28 d | C: HFD I: HFD + extract | Sig. decrease in body wt. & perirenal adipose tissue wt. & epididymal fat pad | Sig. decrease in plasma TG levels; sig. decrease in mitochondrial protein and (UCP) in brown adipose tissue, and in urinary noradrenaline and adrenaline excretion |
Yoshida et al[79] 1995 | Mouse (obese and lean) | Bofu-tsusho-san | 1/4%, 4/7% of wt. of food 8 wk | - | Sig. decrease in body wt. & retroperitoneal white adipose tissue wt. and no change in food intake | Sig. increase in GDP binding dose dependently |
He et al[80] 2008 | Rat (obese by STZ & HFD | Yi-Qi-Yang-Yin-Ye | 2, 4, 8 g/kg 4 wk | - | Body wt. decreased | Decrease in TG/Chol/LDL/FFA/FBG/insulin; improvement of glucose tolerance |
Jeong et al[81] 2008 | Rat (fatty) | Gyeongshang angjeehwan: Liriope platyphylla F.T./Wang & T. Tang (Liliaceae), Platycodongrandiflorum A. DC. (Campanulaceae). Schisandrachinensis K. Koch (Magnoliaceae). Ephedra sinica Stapf (Ephedraceae) | 8 wk | C: Placebo I: Compound | Sig. decrease in food intake & body wt. gain & abdominal fat | Sig. decrease in plasma leptin levels; decrease in circulating TG and inhibition of lipid accumulation in liver; increase of mRNA of genes responsible for FABO |
Park et al[82] 2005 | Rat (obese by diet) | Platycodon grandiflorum | 150 mg/kg 7 wk | C: Convert to NLD/HFD I: Same groups + extract | Sig. decrease in wt. of body & adipose tissues in rats converted to NLD as compared to those remained on HFD | Sig. decrease in fat cell number & size in both I groups as compared to their state before intervention; decrease of FABP expression in HFD group of I |
Akagiri et al[83] 2008 | Mouse (obese by HFD) | Bofutsushosan (BOF) | 1%/4 wk | C: Placebo I: Compound | The wt. of WAT and increase in size of adipocytes inhibited | Expression of UCP1 mRNA in WAT was found but not sig. |
Kim et al[84] 2005 | Mouse (diabetic) | Pine extract (bark and needle) | 21 d | C: Control I: Extract | Sig. decrease in body wt. | Effectively suppressed the increase of postprandial blood glucose level by delaying absorption of diet |
Attele et al[85] 2002 | Mouse (obese diabetic) | Panax ginseng berry | 150 mg/kg (ip) 12 d | C: Control I: Extract | Sig. loss of wt. with a sig. reduction in food intake & a very sig. increase in energy expenditure & body temperature | Sig. improvement in glucose tolerance & sig. reduction in serum insulin levels & plasma chol levels |
- Citation: Hasani-Ranjbar S, Nayebi N, Larijani B, Abdollahi M. A systematic review of the efficacy and safety of herbal medicines used in the treatment of obesity. World J Gastroenterol 2009; 15(25): 3073-3085
- URL: https://www.wjgnet.com/1007-9327/full/v15/i25/3073.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.3073